QNTM (Quantum BioPharma) EBIT per Share : $-15.71 (TTM As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Quantum BioPharma EBIT per Share?

Quantum BioPharma's EBIT per Share for the three months ended in Sep. 2024 was $-4.36. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $-15.71.

During the past 3 years, the average EBIT per Share Growth Rate was 41.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was 34.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Quantum BioPharma's EBIT per Share or its related term are showing as below:

QNTM' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -862 Med: -365.25 Max: 41.2
Current: 41.2

During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of Quantum BioPharma was 41.20% per year. The lowest was -862.00% per year. And the median was -365.25% per year.

QNTM's 3-Year EBIT Growth Rate is ranked better than
84.69% of 823 companies
in the Drug Manufacturers industry
Industry Median: 7.8 vs QNTM: 41.20

Quantum BioPharma's EBIT for the three months ended in Sep. 2024 was $-4.01 Mil.

Quantum BioPharma EBIT per Share Historical Data

The historical data trend for Quantum BioPharma's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum BioPharma EBIT per Share Chart

Quantum BioPharma Annual Data

Trend

Aug15

Aug16

Aug17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-311.25

-152.52

-62.95

-44.72

-29.93

Quantum BioPharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															-4.64	-2.73	-3.41	-5.22	-4.36

Quantum BioPharma EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Quantum BioPharma's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-18.23	/	0.609
=	-29.93

Quantum BioPharma's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-4.005	/	0.918
=	-4.36

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-15.71

Quantum BioPharma (NAS:QNTM) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Quantum BioPharma EBIT per Share Related Terms

Thank you for viewing the detailed overview of Quantum BioPharma's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Quantum BioPharma Ltd (NAS:QNTM) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

0K91:Germany QNTM:Canada

Address

199 Bay Street, Suite 4000, Toronto, ON, CAN, M5L 1A9

Website

https://www.fsdpharma.com

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.